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The 409-residue protein lactadherin (also known MFG-E8) binds
the lipid phosphatidylserine (PS) in a stereospeciﬁc and calcium-
independent manner [1]. Lactadherin was initially identiﬁed by its
association with bovine milk fat globules, appearing as two glycosyl-
ation variants of 47 and 52 kDa, respectively [2]. Besides mammary
epithelial cells [3], lactadherin is also secreted by epididymal epithelial
cells [4], vascular cells [5], stimulated macrophages [6] and stimulated
endometrium cells [7]. Bovine lactadherin comprises two N-terminal
epidermal growth factor homology domains (EGF1 and EGF2), and
the C-terminal region consists of two C domains (C1 and C2), which
share homology with the lipid-binding “C” domains of blood coagula-
tion factor VIII and factor V. These C domains, and especially the C2 do-
mains, confer the PS-binding ability to the coagulations factors andlactadherin [8–10]. The EGF2 domain contains an Arg-Gly-Asp (RGD)
motif that confers binding to the αvβ5 and αvβ3 integrins [9]. It was
hypothesized that lactadherin by the two-sided binding afﬁnities
could operate as an opsonin-facilitating PS-dependent phagocytosis
of apoptotic cells [2,9,10], which was subsequently conﬁrmed in vivo
[6].
The crystal structure of the bovine lactadherin C2 domain reveals a
distorted β-barrel formed by eight of the 19 antiparallel β strands
[11]. Equivalent β-barrel cores are found in the C2 domains of factors
V and VIII, and have been conserved across the family of discoidin-
type homology domains. In analogy with the C2 domains of factors
V and VIII, the membrane interacting part consists of three relatively
large loops termed “spikes” [11]. Mutagenesis studies demonstrated
that solvent-exposed hydrophobic residues, Trp26, Leu28, Phe31,
and Phe81, and/or Gly residues of spikes 1 and 3 most likely partici-
pate in membrane binding [11]. Even though the C2 domain of lactad-
herin closely resembles the corresponding domains in factors V and
VIII, there are small differences which may explain the more efﬁcient
PS-binding of lactadherin [11].
The phospholipid binding characteristics of lactadherin were ini-
tially examined by coating microplate wells with individual pure
phospholipids. In this assay, lactadherin showed afﬁnity toward PS,
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acid, phosphatidyl-glycerol (PG) and cardiolipin, but not to phospha-
tidylcholine (PC) and sphingomyelin [9]. In the same work, implica-
tions for selective binding to negatively charged phospholipids were
also given, as only 2% PS mixed with PC effectively supported lactad-
herin binding. Exclusivity for PS-binding of lactadherin was demon-
strated shortly after in a study using a slightly different setup [12].
Lactadherin also displays low afﬁnity binding to the abundant anionic
phospholipid phosphatidylinositol in extruded vesicles [13]. This
might, in turn, explain why binding could be achieved with pure
phospholipids other than PS. The binding of factor VIII to PS is mark-
edly enhanced by PE [14]. Similarly, lactadherin binding was ﬁrstly
shown to be stimulated with 20% PE at 2% PS, though it hardly had
any effect at 4% PS [9]. However, successive investigations implied
no speciﬁc effect on lactadherin PS-binding [13].
Other membrane-binding features of lactadherin include Ca2+-
independent stereoselective afﬁnity for the L-form of PS and prefer-
ence for membranes with high surface curvature. Lactadherin dis-
plays an almost linear relationship between PS content and the
number of binding sites at low (0–2%) PS levels [13], reaching satu-
ration around 8% PS content. The PS-threshold for lactadherin bind-
ing to membranes has not been determined, but it has been
suggested that lactadherin will bind to cell membranes with a PS
content above 0.5% [15]. Lactadherin thus shows promise as a new
tool for Ca2+ independent PS imaging, and might allow experimen-
tal setups where the benchmark PS-recognizing protein annexin V
cannot be utilized. The use of lactadherin as a PS-localization tool
is accelerating, with the most prominent examples in the ﬁeld of he-
matology (e.g. [16–18]).
Motivated by the central importance of lactadherin–PS interac-
tions, we have carried out a kinetic in vitro investigation to elucidate
steps involved in the binding reaction using puriﬁed bovine lactad-
herin and isolated phospholipid vesicles of different compositions
and sizes. We show that the binding pattern ﬁts to a two-step binding
mechanism involving an initial binding and a second rearrangement
step. This binding step is entirely associated with the C2 domain
and does not involve the EGF domains. Our kinetic assay is sensitive
enough to allow us to investigate binding at very low PS concentra-
tions, and demonstrates signiﬁcant binding at PS contents around
0.03%. Although there is saturation of the degree of binding around
1% PS, the rate constant of binding continues to increase at higher PS
concentrations and is promoted by increased vesicle curvature but
relatively unaffected by increasing PE. Remarkably, the signature
speciﬁcity for PS is abolished in dodecylphosphocholine micelles,
where other anionic phospholipids elicit the same response as PS.
This indicates that the vesicular environment is essential for appro-
priate presentation of the PS moiety.
2. Materials and methods
2.1. Materials
Lactadherin (409 residues, 45,590 Da), in both glycosylation
forms, was prepared as described previously [2]. Purity was checked
by SDS-PAGE and N-terminal amino acid sequencing and shown to
be N97%. Protein concentrations were determined by amino acid
analysis based on o-phthaldialdehyde derivatization. Discoidin C2 do-
main of lactadherin (residues 252–409) was produced as described in
Ref. [11]. 1,2-Diacyl-sn-glycero-3-phospho-L-serine (Sigma, P7769)
(denoted PS) and 3-sn-phosphatidyl-ethanolamine (Sigma, P7693)
(PE) were from bovine brain, and L-α-phosphatidylcholine (Sigma,
P3556) (PC) was from egg yolk. These lipids had a mixture of differ-
ent chain lengths and were used for experiments involving bilayer
vesicles, where all lipids are incorporated homogeneously into vesi-
cles. Given that lactadherin is believed to bind to the interfacial region
rather than penetrating to the hydrocarbon layer, the existence ofdifferent chain lengths in the hydrocarbon layer is unlikely to affect
binding to any signiﬁcant degree. Dodecylphosphocholine (DPC),
dilauroylphosphatidylserine (DLPS), dilauroylphosphatidyl glycerol
(DLPG) and dilauroylphosphatidylcholine (DLPC) were from Avanti
(Alabaster, AL). These lipids all had the same 12-carbon chain length
and were used for experiments involving micelles, where matching
chain length was important to facilitate appropriate mixing of differ-
ent components. Chemicals were of the highest analytical grade and
from Sigma-Aldrich or Merck unless speciﬁed.
2.2. Preparation of mixed micelles and vesicles
Mixed micelles were prepared by dissolving solid phospholipids
(w/v) in chloroform:methanol (95:5) to obtain the desired phospho-
lipid weight ratios. All concentrations are given as mg/ml because the
mixture of different chain lengths precludes calculation of molar con-
centration. The solvent was evaporated by a stream of dry nitrogen for
at least 2 h followed by exposure to vacuum for the same length of time
until a dry lipid ﬁlm was observed. This was done prior to suspension
(10 mg/ml) of the phospholipids in 75 mM NaH2PO4–Na2HPO4, pH
7.4. Small unilamellar vesicles of phospholipids were prepared by soni-
cation using a Bandelin Sonopuls (Bandelin Electronics GmbH, Berlin,
Germany) with 50% power and 10% cycles, typically for a few minutes
while keeping sample on ice and ensuring it did not heat up beyond
room temperature, until no further optical clearing of the suspension
was observed. Samples were ﬂushed with nitrogen prior to use to
minimize oxidation of unsaturated bonds. The sonicated samples
were centrifuged to remove titanium particles before use. Unless
otherwise stated, all vesicles were sonicated just before the experi-
ment and were used within 2 days of preparation. Extrusion of vesi-
cles with ﬁlters of pore sizes 200, 100 and 50 nm was carried out
using a 15 mL thermobarrel extruder (Northern Lipids, Vancouver)
using two stacked ﬁlters as described [19]. Dynamic light scattering
conﬁrmed that the average vesicle size was within the expected
range for each extrusion fraction, though there was some overlap be-
tween the different fractions [20].
2.3. Steady state ﬂuorescence experiments
Steady state ﬂuorescence experiments were performed utilizing
a Photon Technologies, Inc. cw spectroﬂuorometer equippedwith a Pel-
tier heating and cooling sample chamber. Experiments were performed
in 10×10×40mm quartz cuvette. A U330 ﬁlter was placed in the exci-
tation pathway to minimize 2nd order and stray light. Emission spectra
were recorded for 40 nM lactadherin in Tris-buffered saline pH 7.4 at
20 °C. Spectrawere recorded approximately 5 min after addition of ves-
icles. Excitation wavelength was 280 nm and bandpass for excitation
and emission was set at 2 nm. Displayed results are the average of 3
separate experiments each recorded in triplicate.
2.4. Stopped-ﬂow experiments
Kinetic ﬂuorescence measurements were performed on an Ap-
plied Photophysics (Leatherhead, U.K.) SX18MV stopped-ﬂow appa-
ratus, using an excitation wavelength of 280 nm and emission
through a 320 nm glass ﬁlter. All experiments were carried out at
25 °C in 75 mM sodium phosphate pH 7.4. Vesicles or micelles of a
given composition were mixed 1:1 with protein solution (either
full-length lactadherin or the C2 domain) to give a ﬁnal protein con-
centration of 0.66 μM (based on ε2801mg/ml=1.72). Data typically ﬁtted
to two exponential relaxation phases according to the following
equation:
Signal tð Þ ¼ Amp1  exp −k1  tð Þ þ Amp2  exp −k2  tð Þ þ c ð1Þ
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for the ﬁrst and second phase and c is an experimental offset. To
avoid bias, ratios between Amp1 and Amp2 were not ﬁxed.
The rate constant for the ﬁrst (fast) relaxation phase was ﬁtted to
the following linear equation:
k1 ¼ kass  vesicle½  þ kdiss ð2Þ
where kass is the second-order association rate constant of binding
and kdiss is the ﬁrst-order dissociation rate constant of binding.
The rate constant for the second (slow) relaxation phase was
ﬁtted to the hyperbolic equation:
k2 ¼ kslow  vesicle½ = KD þ vesicle½ ð Þ ð3Þ
where kslow is the slow conformational change associated with the
formation of the ﬁnal bound state in Scheme 1 and KD=kdiss/kass=
[Lact][vesicle]/[Lact:vesicle] is the equilibrium dissociation constant
describing the formation of the initial (Lact:vesicle)* complex.
2.5. Determination of critical micelle concentration (cmc) of mixed
micelles
This was done using the pyrene assay as described [21,22]. Brieﬂy,
we determine the ratio between the emission intensity at two wave-
lengths (I1=372.5 and I3=383.5 nm) upon excitation at 355 nm.
I3/I1 is around 0.6 in the absence of surfactant but increases to a pla-
teau value of 0.85–0.9 in the presence of micelles, depending on the
speciﬁc surfactant headgroups. We operationally deﬁne the cmc as
the surfactant concentration at which the ratio reaches the plateau
value.
3. Results
3.1. Fluorescence change of lactadherin upon binding to
phosphatidylserine-containing vesicles
The crystallographic structure of the lactadherin C2 domain indi-
cates an exposed Trp residue on the putative membrane-binding in-
terface [11]. This suggests that membrane interactions may lead to
altered intrinsic ﬂuorescence. To test this possibility, lactadherin was
incubated with sonicated vesicles containing PS (Fig. 1A). The results
indicated that binding to these vesicles causes an overall ﬂuorescence
of increase of approximately 10% and a blue shift of approximately
2 nm in the emission spectrum. These results are consistent with a
membrane-binding change in which at least one Trp residue becomes0
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Fig. 1. (A) Lactadherin ﬂuorescence emission spectra obtained without (joined lines)
and with (stippled lines) sonicated phospholipid vesicles (composition 4PS:20PE:76PC
4:20:76). (B) Time proﬁles for the binding of lactadherin to vesicles containing 99% PC
and either 1% PS or 1% PG, monitored by the change in lactadherin Trp ﬂuorescence.
The time proﬁles with PS are ﬁtted to two exponential decays (Eq. 1). Note the com-
plete lack of ﬂuorescence change when PS is replaced by PG, emphasizing the speciﬁc
binding of lactadherin to the PS group. (C) Dependence of the fast (ﬁlled circles) and
slow (empty circles) rate constants on vesicle concentration for binding of lactadherin
to vesicles containing 1% PS and 99% PC. Data for the fast rate constants for binding of
the recombinant C2 domain to the same type of vesicles (crosses) are shown for com-
parison. Joined lines indicate best ﬁts to full-length lactadherin data. Fast rate constants
are ﬁtted to a linear equation (Eq. 2) to yield a slope (kass) of 184±6 (mg/ml)−1 s−1
and an intercept (kdiss) of 22.0±3.5 s−1, while the slow rate constants are ﬁtted to a
hyperbolic equation (Eq. 3) to give a plateau value (kslow) of 37±6 s−1. Eq. (3) yields
an apparent equilibrium constant KD=0.34±0.13 mg/ml while Eq. (2) predicts an
equilibrium constant KD=kdiss/kass=0.12±0.02 mg/ml. The stippled hyperbolic
curve indicates the ﬁt to the slow rate constants using a ﬁxed equilibrium constant
of 0.12 mg/ml. The dashed straight line is the best ﬁt to the fast rate constants for
the C2 domain, which yields a slope of 193±16(mg/ml)−1 s−1 and an intercept of
28±10 s−1, values which within error are identical to those of full-length lactadherin.
Inset: Change in the amplitude of the fast phase with increasing lipid concentration.
The joined line is the best ﬁt to Eq. (3).
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sion in the membrane or may be due, in part, to a conformational
change. This change in intrinsic ﬂuorescence provides a useful signal
for measuring the kinetic properties of membrane interaction.
3.2. Binding of lactadherin can be described by a two-step binding
mechanism and only involves the C2-domain
When full-length lactadherin is mixed with synthetic phospholip-
id vesicles containing 99% PC and 1% PS in a stopped-ﬂow apparatus
and the reaction is followed by changes in Trp ﬂuorescence, we obtain
an increase in ﬂuorescence over time which can be ﬁtted to two expo-
nential decays (Fig. 1B). This signal is completely absent when PS is
replaced by the phospholipid phosphoglycerol (PG), which like PS
has an overall negative charge of −1 but lacks the serine group.
There is no signal when the amino acid Trp is used instead of lactad-
herin, irrespective of which lipid is used (data not shown). Both these
sets of data indicate that there is no signiﬁcant contribution of light
scattering to the reaction, which therefore must reﬂect change(s)
that occur upon membrane binding, and is entirely consistent with
lactadherin's speciﬁcity for PS [9,13]. The signal change associated
with the fast phase increases signiﬁcantly with increasing vesicle con-
centration, reaching a plateau level above ~0.5 mg/ml vesicle (insert
to Fig. 1C) while the signal change for the slow phase is smaller, de-
termined with greater error and shows more ﬂuctuation (data not
shown). The rate constant for the fast phase increases linearly with
lipid concentration while that of the slow phase reaches a plateau
in approximately the same concentration range as the amplitude
of the fast phase (Fig. 1C). As we measure total emission above
320 nm, we cannot determine whether the two phases lead to
changes in the emission spectrum in overall intensity. Rather, we
use the data as evidence for two distinct processes associated with
vesicle interaction. The simplest interpretation of the kinetic data is
a two-step binding mechanism between protein (Lact) and lipid
with the following parameters:
Here kass is the association rate constant describing the binding of
lactadherin to lipid, kdiss the rate constant for the dissociation of this
complex and kslow a conformational or membrane insertion change
from the initial complex to the ﬁnal bound state. In this model, the
slope of the linear plot in Fig. 1C (Eq. (2) inMaterials andmethods) cor-
responds to kass=184±6(mg/ml)−1 s−1) and the intercept is
kdiss=22.0±3.5 s−1. The hyperbolic concentration dependence of the
slow phase reﬂects the fact that the conformational change of this
step is not directly dependent on protein concentration but rather on
the fraction of the protein that is complexed as (Lact:lipid)*. Once we
have reached vesicle concentrations where essentially all lactadherin
complexes to vesicles, the rate limiting step becomes the conformation
change described by kslow. This concentration dependence is described
by Eq. (3). Strictly speaking, a hyperbolic ﬁt of the slow rate constant
versus vesicle concentrations in this scheme presupposes a rapid equi-
librium between free and bound lactadherin which is not affected by
the slow phase, in other words that kslowbkdiss. This is not quite correct,0
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1023D.E. Otzen et al. / Biochimica et Biophysica Acta 1818 (2012) 1019–1027as the hyperbolic ﬁt in Fig. 1C predicts a kslow value of 37±6 s−1, which
is almost twice as large as kdiss. However, in practice the discrepancy is
not very large. The ratio kdiss/kass=0.12±0.02 mg/ml (derived from
the fast phase; concentration refers to vesicles) describes the equilibri-
um constant for binding of lactadherin to vesicles in the ﬁrst step,
and this is in the same range as the equilibrium constant KD=0.35±
0.14 mg/ml (derived from the slow phase). As shown in Fig. 1C, the
two equilibrium values lead to quite similar hyperbolic ﬁts. Further,
the model assumes that lipids are in excess, leading to pseudo-ﬁrst
order binding kinetics in the ﬁrst step. We justify this assumption on
two grounds. Firstly, the ﬁnal protein concentration (after mixing) is
0.03 and 0.012 mg/ml (full lactalbumin and C2 domain, respectively)
which is well below the ﬁnal lipid concentration for most of our data
points. Secondly, a three-fold reduction in protein concentration does
not lead to any signiﬁcant change in kinetics (data not shown).
Thus we conclude based on these data that lactadherin binds in a
two-step mechanism to vesicles, in which the ﬁrst step is a binding
event while the second step involves a change in Trp ﬂuorescence
that can be ascribed to either a conformational change in lactadherin
or a change in the extent of insertion into the phospholipid mem-
brane. It is not possible based on the present data to distinguish be-
tween these two possibilities.
Having established the speciﬁcity for PS lipids, we next investigat-
ed whether the binding was associated with the C2 domain. A recom-
binantly expressed C2 construct was subjected to the same studies
and yielded identical results within error (data for kfast shown in
Fig. 1C). We therefore conclude that the binding reaction monitored
by stopped-ﬂow can entirely be attributed to the interaction between
the C2 domain and PS-containing vesicles.
3.3. As little as 0.03% PS leads to detectable binding, and the dynamics
(but not afﬁnity) of interactions are promoted by smaller vesicles but
not signiﬁcantly by inclusion of PE lipids
Previous studies have shown that lactadherin can bind to cell mem-
braneswith a PS content above 0.5% [15].We decided to investigate the
lower limits of binding by monitoring the binding reaction using vesi-
cles containing 0.03–20% PS. It was possible to detect binding over the
entire interval, though the signals and rate constants diminished with
decreasing PS content. Nevertheless, linear correlations between the
fast rate constant and vesicle concentration were detected in all cases
(Fig. 2A), and these made it possible to determine the kass values with
good precision (Fig. 2B). The kdiss values and kslow values stayed essen-
tially constant with decreasing PS content, but the decreasing signal
made it difﬁcult to determine them with the same precision, so we
focus on kass. This increases steeply with the percentage of PS up to
around 1% PS, after which there is a more measured increase (Fig. 2B).
Interestingly, the maximal amplitude associated with each PS value
(determined as in the insert to Fig. 1C) also increases with PS but only
up to 1% PS, after which it stays constant. In fact themaximal amplitude
data can be ﬁtted to a binding isotherm to yield an apparent binding
constant of 0.15±0.03% PS (Fig. 2C), meaning that vesicles containing
as little as 0.15% PS have half the maximal binding capacity of PS-
containing vesicles. Further increases in PS content promote the kinet-
ics of binding (and by implication the afﬁnity of binding, since the dis-
sociation constant does not appear to change) but does not to
any signiﬁcant extent affect the capacity of binding (i.e. the amount of
protein that can bind to vesicles). We conclude that lactadherin is re-
markably sensitive to PS, detecting it at concentrations at least an
order of magnitude lower than previously reported using equilibrium
conditions [15].
Lactadherin has also been reported to be sensitive to the degree of
membrane curvature [13], and our kinetic model provides a sensitive
means of investigating this in further detail. We prepared different
sized vesicles by extruding them successively through ﬁlters of de-
creasing size to yield vesicles of diameter 200, 100 and 50 nm. Finally
1024 D.E. Otzen et al. / Biochimica et Biophysica Acta 1818 (2012) 1019–1027the remaining portion of vesicles was sonicated to yield vesicles of
around 30 nm. Note that although extrusion clearly leads to the for-
mation of vesicles with different size distribution ranges as deter-
mined by dynamic light scattering [20], there is some degree of
overlap between the different fractions. We therefore focus on the
general trends in the results and do not attempt to make quantitative
predictions. Although all vesicles yielded the customary linear plots
when the fast rate constant was plotted versus vesicle concentration
(Fig. 3A), there was a clear decrease in both kass and kdiss with increas-
ing vesicle size (Fig. 3B). This parallel decrease meant that the disso-
ciation constant KD=kdiss/kass remained essentially constant
irrespective of vesicle size (Fig. 3C). However, as is common for
many such ligand-binding experiments, the dissociation constant is
determined with considerable error because of the large error on
kdiss. An alternative approach is therefore to determine afﬁnity using
the amplitude of the major binding phase as in the insert to Fig. 1C.
Although the KD values for individual vesicle sizes determined by
the two approaches are similar, there is a much clearer trend with
the amplitude data that the afﬁnity decreases with increasing vesicle0
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When we use these KD values to back-calculate kdiss using the already
determined kass values, kdiss remains essentially constant for extruded
vesicles of size 50–200 nm but is signiﬁcantly larger for the sonicated
vesicles (Fig. 3B).
In view of the conﬂicting data on the effect of PE on lactadherin
binding [9,13], we also investigated the kinetics of binding of lactad-
herin to vesicles with 1% PS and different concentrations of PE. Once
again linear plots were observed for the fast rate constants (Fig. 4A),
and the kass values increased linearly with the PE content (Fig. 4B).
However, the slope of this plot was around 8.6±1.6, which is around
a third of the value (27.3±2.3) for corresponding changes in PS in the
range of 1–20% PS (Fig. 2B). The kdiss values changed much less
(Fig. 4B). Clearly PE increases the afﬁnity of lactadherin for membranes,
although this effect is not as strong as observed for PS and is alsowholly
dependent on PS; no binding was observed in the absence of PS (data
not shown). Just as remarkable was the change in amplitude. In the ab-
sence of PE, the amplitude of binding is negative, corresponding to an
increase in ﬂuorescence upon binding and conformational change.0
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increasingly less negative and switches to positive around 10% PE
(Fig. 4C), while that of the slow phase remains negative throughout
(Fig. 4D). There is a clear linear relationship between the maximal am-
plitude and the PE content. This suggests a simple change in the ﬂuores-
cence properties of the vesiclewhichmeans that themore PE is present,
the more the Trp ﬂuorescence is quenched by the vesicle upon binding.
3.4. Binding of lactadherin to micelles containing PS
The increased interaction with smaller vesicles suggests that lac-
tadherin–vesicle interactions are promoted by increased curvature,
i.e. increased exposure of PS residues. A simple way to increase this
exposure is to replace vesicles with micelles, where the individual
components are less closely packed, more surface exposed and in a
more rapid exchange with surroundings [23]. We do this by replacing
the diacylated phosphatidyl choline with the single chain surfactant
dodecylphosphocholine (DPC) which forms micelles rather than ves-
icles. The critical micelle concentration for DPC is around 1.5 mM.
However, upon adding the diacylated phospholipids DLPS, DLPG or
DLPC (which all have an alkyl chain length of 12 atoms like DPC), mi-
celles form at signiﬁcantly lower concentrations (Fig. 5A), and micelle
formation is complete around 0.5 mM total surfactant. This is not sur-
prising, given that the diacylated phospholipids have a much stronger
tendency to associate than their single-chain counterpart and will
therefore promote mixed micelle formation. Therefore we can safely
assume that micelles are present from 0.5 mM surfactant and up.
When lactadherin is mixed with micelles containing 10% DLPS at
micellar concentrations, we observe two exponential decays as for
the corresponding vesicles (Fig. 5B). However, there are several dif-
ferences compared to their closest counterpart, namely sonicated
vesicles containing 10% PS. Firstly, the rates are much lower. The
slope of the plot is around 4 mM−1 s−1 or ~12(mg/ml)−1 s−1 while
the corresponding slope for vesicles with 10% PS is interpolated
from Fig. 2B to be ~400(mg/ml)−1 s−1. Secondly, the slow rate con-
stant for micelle interactions does not follow a hyperbolic relation-
ship, unlike that of the vesicles (cfr. Fig. 1C), suggesting that we do
not have a simple two-state binding but possibly two parallel binding
steps. Thirdly and most importantly, similar exponential decays are
observed when DLPS is replaced with the anionic phospholipid
DLPG and even with the zwitterionic lipid DLPC (data shown for
DPC:DLPG in Fig. 5C; similar data for DPC:DLPC). The data are more
scattered and do not show a clear linear dependence, but there is
nonetheless a marked contrast to vesicles where DLPG failed to elicit
any response (Fig. 1B). Using a completely different pair of surfac-
tants (SDS instead of DLPS/DLPG and dodecyl maltoside instead of
DPC) also gives rise to the same two-exponential decay with rate con-
stants in the same range (data not shown), while DPC alone leads to a
single exponential decay similar to the slow phase in Fig. 5B. Below
the cmc, the kinetics in both DPC:DLPS and DPC:DLPG micelles are
even more complex, giving rise to three exponential decays where
the fast phase has rate constants up to 400 s−1 (data not shown).
All this indicates that lactadherin–micelle binding involves more
than simple recognition of the PS moiety. The signals probably reﬂect
more general protein–surfactant interactions (for a more detailed ac-
count of these phenomena, see Ref. [24]). This nicely illustrates that
the intact vesicle structure is vital for the correct presentation of PS
for recognition by lactadherin.Fig. 5. Interaction of lactadherin with micelles containing PS and other phospholipids.
(A) Determination of the critical micelle concentration of DPC with and without diacy-
lated phospholipids using pyrene ﬂuorescence. (B) Rate constants for binding of lac-
tadherin to micelles containing 90% DPC and 10% DLPS (molar ratio). The linear ﬁt
for the fast phase yields a slope of 3.85±0.37 mM−1 s−1 and an intercept of 2.59±
0.23 s−1. The corresponding values for the slow phase are 0.80±0.06 mM−1 s−1 and
−0.38±0.18 s−1. (C) Data as in panel B using DLPG instead of DLPS. The lines are
shown to guide the eye.
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It is recognized that redistribution of PS to the outer leaﬂet of the
plasma membrane is crucial to recruit numerous signaling molecules
or create an environment that facilitates speciﬁc enzymatic and/or bi-
ological activities. For example, PS exposed on activated platelets or
long term stored red blood cells serves as procoagulant surfaces sup-
porting the generation of factors VIIIa and Xa, which lead to conver-
sion of prothrombin to thrombin by coagulation factor Xa in the
presence of calcium and factor Va [25]. Lactadherin has been shown
to be a highly suitable probe for PS exposure. Accordingly, the present
study provides detailed data for the binding kinetics of lactadherin to
PS-containing membranes. Based on these data, we conclude that lac-
tadherin binds in a two-step mechanism to vesicles, a fast initial bind-
ing event followed by a slower step that reﬂects either a change in
lactadherin conformation or the extent of binding to the phospholipid
membrane. With the present data it is not possible to distinguish be-
tween these two possibilities.
It has previously been shown that factors VIII and V bind to PS-
containing vesicles via a multistep process with a rapid and a succes-
sive slower association step [26]. Both the C1 and C2 domains of fac-
tor VIII participate in membrane binding [8,27]. In fact, the C2 domain
of factor VIII differs from the C2 domain of lactadherin in that mem-
brane binding of the isolated domain is of very low afﬁnity and does
not have PS speciﬁcity [28]. Thus, a plausible multi-step mechanism
binding mechanism for factor VIII involves sequential membrane en-
gagement of the C1 and C2 domains. A similar model may be appro-
priate for lactadherin, though it appears more likely that the C2
domain makes the primary membrane engagement and may be fol-
lowed by membrane engagement of the C1 domain. The differences
between the membrane binding patterns of the C2 domain of lactad-
herin and the C2 domain of factor VIII illustrate that the membrane
interactions are more complex than the overall structural homology
had suggested.
Upon comparison with annexin V, it has been suggested that use
of lactadherin may enable a more accurate description of the degree
of PS exposure when studying blood platelet activation and/or apo-
ptosis [16]. The present work adds new knowledge to the lower limits
of PS-detection lactadherin. Even at a PS content of 0.03%, binding
was still observed. Sensitivity at this level might enable collection of
more information about the timeline of PS-exposure during the apo-
ptosis and studies of phospholipid asymmetry during normal and
pathological processes and provide more insight into the physiologi-
cal role of lactadherin. We have previously shown that lactadherin
has a preference for curved membranes, with a four-fold difference
in afﬁnity between small and large unilamellar vesicles [13]. This fea-
ture indicates a preference for certain membrane structure, e.g. pseu-
dopods, ﬁlopodia-like extensions, membrane vesicles, small milk fat
globlets or platelet-derived microvesicles. Our kinetic data nicely re-
produce this curvature preference, showing that the afﬁnity approxi-
mately doubles as we go from large (200 nm) to small sonicated
(30 nm) vesicles. Furthermore, the data suggest that both association
and dissociation kinetics are affected as we go from the 30 nm vesi-
cles to the next size class (50 nm), while subsequent size increases
have a smaller kinetic effect but mainly decrease association kinetics.
This strong sensitivity to small vesicles seems reasonable as sonicated
vesicles are inherently unstable compared to larger vesicles [29] and
harbor a signiﬁcantly greater degree of membrane defects associated
with increased curvature compared to even the smallest extruded
vesicles.
Lactadherin's membrane-binding requirements parallel those of
factor VIII to great extent. However, when it comes to the impact of
PE the picture for lactadherin is less clear in the literature [9,13].
The present stopped-ﬂow experiments show two things: ﬁrstly, PE
does increase the afﬁnity of lactadherin for vesicles (by increasing
the association rate constant) but only in the presence of PS and notas much as this lipid on a molar basis. We interpret this to mean
that PE acts as an ancillary lipid that can promote binding to whatever
PS is present. Secondly, there is a clear linear relationship between
the maximal amplitude and the PE content. This suggests a simple
change in the ﬂuorescence properties of the vesicle which means
that the more PE is present, the more the Trp ﬂuorescence is
quenched by the vesicle upon binding. That this does not affect the
slow phase indicates that the second step does not involve any
changes in the interaction with the PE moiety (either formation or
dissolution of interactions), in other words the second phase is the
same in the absence or presence of PE. Thus both observations strong-
ly indicate that PE only affects the very ﬁrst part of the docking of lac-
tadherin onto PS-containing vesicles.
To investigate whether the increased lactadherin–vesicle interac-
tions are stimulated by augmented exposure of PS residues due to in-
creased curvature, we substituted vesicles with micelles comprising
single and dodecylphosphocholine and diacylated phospholipids.
The experiments, which also employ use of SDS and dodecyl malto-
side, indicate that lactadherin–micelle binding involves more than
simple recognition of the PS moiety. The loss of speciﬁcity probably
reﬂects more general protein–surfactant interactions, of which there
is an almost overwhelming variety of different types (for a more de-
tailed account of these phenomena, see Ref. [24]). This nicely illus-
trates that the intact vesicle structure is vital for the correct
presentation of PS for recognition by lactadherin.
In conclusion, lactadherin demonstrates an even greater sensitivi-
ty toward PS than previously reported, detecting PS in vesicles at a
level at least an order of magnitude lower than previously reported
[15]. Lactadherin binds to PS vesicles in a manner that is promoted
by content of both PE and increased membrane curvature. Lactad-
herin and PS interaction is mediated by the discoidin C2 domain
and is critically dependent on vesicle structure since speciﬁcity is
completely destroyed in micelles.Acknowledgements
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